Study to Assess Adverse Events and Compare How Crushed, Ground, and Intact Oral Tablets Venetoclax Moves Through the Body of Healthy Female Adult Volunteers
Clinical trial NCT05909553 · COMPLETED
Trial details
- NCT number
- NCT05909553
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-15
- Primary completion
- 2023-09-22
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.